Alexandria Real Estate Equities Inc. ($ARE) Stock Forecast: Up 5.3% Today

What is Alexandria Real Estate Equities Inc.?

Alexandria Real Estate Equities (NYSE: ARE) is a prominent real estate investment trust (REIT) specializing in life science and technology campuses. The company focuses on providing space for leading innovation and research companies in key urban innovation clusters.

Why is Alexandria Real Estate Equities Inc. going up?

ARE stock is up 5.3% on Feb 13, 2026 18:12

• ARE experienced a strong bullish movement today following the announcement of a successful $750 million senior notes offering due in 2036. This strategic move to refinance debt and extend maturities positively impacted investor sentiment.
• The company's ability to navigate an investor lawsuit while executing a significant debt refinancing showcases its commitment to financial stability and transparency, contributing to the bullish market movement.
• By reducing reliance on short-term funding and enhancing balance-sheet flexibility, ARE demonstrated proactive financial management, which likely resonated well with investors and contributed to the positive market response.

ARE Price Chart

ARE Technical Analysis

ARE News

Alexandria Balances Investor Lawsuit With Large Debt Refinancing Shift

Alexandria Real Estate Equities (NYSE:ARE) is navigating an investor lawsuit concerning alleged misrepresentation of leasing metrics for a Long Island City property, while simultaneously executing a significant debt refinancing. The company is upsizing a tender offer for existing notes and issuing new $750 million senior unsecured notes due 2036, swapping shorter-term commercial paper for longer-term debt, which impacts its interest costs and maturity profile. These developments coincide with a substantial decline in the company's share price over the past year.

https://simplywall.st/stocks/us/real-estate/nyse-are/alexandria-real-estate-equities/news/alexandria-balances-investor-lawsuit-with-large-debt-refinan/amp

Alexandria Equities Prices $750 Million Senior Notes Offering

Alexandria Real Estate Equities, Inc. (ARE) has successfully priced a $750 million offering of 5.25% senior notes due in 2036. This underwritten offering, which is fully guaranteed, is expected to settle around February 25, 2026, and will be used primarily to repay commercial paper borrowings associated with a previous cash tender offer for older senior notes. This strategic move aims to extend debt maturities and enhance the company's balance-sheet flexibility by reducing reliance on short-term funding.

https://www.tipranks.com/news/company-announcements/alexandria-equities-prices-750-million-senior-notes-offering

Alexandria Real Estate Equities, Inc. Announces $750 Million Senior Notes Offering

Alexandria Real Estate Equities, Inc. announced a $750 million senior notes offering due in 2036, with notes priced at 99.679% and a 5.25% interest rate. The proceeds will be used to repay borrowings from its commercial paper program. The offering is expected to close around February 25, 2026, and is not contingent on the completion of a tender offer.

https://www.tradingview.com/news/tradingview:fbe14d8bcfb2f:0-alexandria-real-estate-equities-inc-announces-750-million-senior-notes-offering/

Biogen Announces Board Chair Transition

Biogen Inc. announced that Dr. Maria C. Freire has been elected as the new Chair of the Board of Directors, succeeding Caroline Dorsa who is retiring. Dr. Freire, a board member since 2021, will assume the role after the Company’s 2026 Annual Meeting. The transition marks a new chapter for Biogen, with leadership confident in Dr. Freire's extensive scientific and drug development background to guide the company's growth and pipeline.

https://www.globenewswire.com/news-release/2026/02/11/3236726/0/en/biogen-announces-board-chair-transition.html

Biogen Announces Board Chair Transition

Biogen Inc. announced that Dr. Maria C. Freire has been elected as the new Chair of its Board of Directors, effective after the 2026 Annual Meeting of Stockholders on June 9, 2026. Dr. Freire will succeed Caroline Dorsa, who is retiring from the board. Dr. Freire, who joined the board in 2021, brings extensive experience in biomedical innovation and drug development to her new role.

https://investors.biogen.com/news-releases/news-release-details/biogen-announces-board-chair-transition

Trending Today

QTUM ($QTUM) Crypto Forecast: Down 5.1% Today

Leidos Holdings Inc. ($LDOS) Stock Forecast: Up 5.8% Today

Crude Oil ($CRUDE) Commodity Forecast: Up 5.1% Today

Garmin Ltd. ($GRMN) Stock Forecast: Up 9.3% Today

Upwork Inc. ($UPWK) Stock Forecast: Up 7.2% Today

Global Payments Inc. ($GPN) Stock Forecast: Up 16.8% Today

Palo Alto Networks Inc. ($PANW) Stock Forecast: Down 7.0% Today

Opendoor Technologies Inc. ($OPEN) Stock Forecast: Up 5.5% Today

Genuine Parts Company ($GPC) Stock Forecast: Down 5.3% Today

Riot Platforms, Inc. ($RIOT) Stock Forecast: Up 6.6% Today

Alexandria Real Estate Equities Inc. Price History

07.00.2026 - ARE Stock was up 7.1%

• Despite challenges like securities class action lawsuits, a real estate impairment charge, and unmet financial expectations in Q3 2025, ARE's stock displayed a bullish movement.
• The unveiling of a significant biosciences campus plan in Redwood City likely had a positive impact on investor sentiment towards ARE, hinting at growth prospects in the life sciences field.
• Market sentiment varies, evident in diverse analyst price targets and ongoing legal scrutiny, reflecting investor deliberation on balancing the company's current undervaluation against future uncertainties.
• The stock's recent increase may be attributed to investors factoring in the reminder of the securities class action lawsuit and the repercussions of disappointing financial results, which might already be factored into the stock price.

03.11.2025 - ARE Stock was down 8.2%

• ARE stock experienced a strong bearish movement due to a combination of factors:
• Significant decrease in its quarterly cash dividend for the fourth quarter of 2025 to strengthen its balance sheet and financial flexibility, possibly disappointing income-seeking investors.
• Securities fraud class action lawsuit alleging failure to disclose material information and misrepresentation of leasing volume and development pipeline likely contributing to negative sentiment.
• Market trends were mixed, with companies like American Eagle Outfitters and Microchip Technology experiencing stock rises due to better-than-expected earnings, whereas others like Netflix and ARE faced declines due to weak guidance and legal issues.

29.00.2026 - ARE Stock was down 5.4%

• ARE reported a substantial net loss, impairment charge, and dividend cut, leading to a 6.6% decline in its stock price. These financial struggles, along with ongoing lawsuits and occupancy pressures, have raised concerns among investors.
• A major investment firm increased its stake in ARE by 22%, indicating confidence in the long-term prospects of the company despite its current difficulties.
• Analysts have given ARE an average "Hold" recommendation, with varying fair-value estimates, reflecting uncertainty about its future performance. The planned asset sales and debt tender offers are seen as necessary for reshaping the company's balance sheet but may lead to short-term occupancy dips and potential dividend cuts.
• The bearish movement of ARE contrasts with the positive performance of a biopharmaceutical firm, which has seen a significant rise in stock price due to promising drug trial results. This juxtaposition highlights the diverging fortunes within the healthcare and real estate sectors.

28.00.2026 - ARE Stock was down 5.1%

• The bearish movement in ARE's stock today can be attributed to the significant net loss reported in Q4 2025, primarily due to real estate impairment charges, which impacted investor confidence in the company's financial health.
• Despite exceeding AFFO and revenue estimates, the market may have reacted negatively to the decline in rental income and operating occupancy, raising concerns about the company's ability to maintain profitability in the near term.
• The ongoing high vacancy rate in the life sciences building in University City, Philadelphia, despite securing a substantial loan, may have also contributed to the bearish sentiment surrounding ARE, reflecting broader uncertainties in the real estate sector.
• Overall, the contrasting narratives of strong FFO resilience but significant net losses have likely led to mixed interpretations of ARE's future profitability, prompting the bearish market movement today.

28.00.2026 - ARE Stock was down 5.0%

• Alexandria Real Estate Equities (ARE) reported a significant net loss for Q4 2025, mainly due to real estate impairment charges, leading to bearish sentiments among investors.
• Despite exceeding AFFO and revenue estimates, the company faced challenges such as a decline in occupancy and negative rental rates, contributing to the bearish market movement.
• Analysts' concerns about weak interest coverage and dividend instability may have further fueled the bearish narrative surrounding ARE's financial health and future profitability.
• The ongoing development in Philadelphia's life sciences sector, as seen with Brandywine securing a loan for a mostly vacant building, highlights potential competition and market dynamics affecting ARE's performance.

13.01.2026 - ARE Stock was up 5.3%

• ARE experienced a strong bullish movement today following the announcement of a successful $750 million senior notes offering due in 2036. This strategic move to refinance debt and extend maturities positively impacted investor sentiment.
• The company's ability to navigate an investor lawsuit while executing a significant debt refinancing showcases its commitment to financial stability and transparency, contributing to the bullish market movement.
• By reducing reliance on short-term funding and enhancing balance-sheet flexibility, ARE demonstrated proactive financial management, which likely resonated well with investors and contributed to the positive market response.

27.00.2026 - ARE Stock was down 2.6%

• Concerns over a potential dividend cut and a slowdown in biopharma research spending negatively impacted leasing demand, leading to the bearish movement in ARE stock.
• The exit of ClearBridge Investments from its position in ARE due to ongoing uncertainty and the dividend cut added to the negative sentiment surrounding the stock.
• Despite reporting strong Q4 financial results with FFO per share exceeding estimates, the market reaction was muted, indicating investor caution towards the challenging revenue environment projected for 2026.
• The combination of missed earnings expectations, concerns over future revenue growth, and overall market sentiment contributed to the bearish movement in Alexandria Real Estate Equities (ARE) stock today.

11.01.2026 - ARE Stock was down 5.0%

• The bearish movement in ARE's stock today can be attributed to the challenges the company is facing due to oversupply and weak demand in the life sciences real estate market.
• Despite strong financials and management, the muted growth prospects for the next few years, influenced by industry headwinds and a shift in capital towards AI, have likely contributed to investor concerns and the negative market movement.
• The pricing of a $750 million senior notes offering by Alexandria Real Estate might have also impacted the stock negatively, as investors may be wary of increased debt levels and interest expenses affecting future profitability.
• The significant increase in institutional stake by Oppenheimer Asset Management Inc. could indicate a long-term bullish outlook on the company, but the short-term market sentiment seems to have been influenced more by the challenges and uncertainties.

12.01.2026 - ARE Stock was down 5.7%

• The decline in ARE's stock today could be linked to challenges stemming from oversupply and weak demand in the life sciences real estate market.
• The suggestion to consider adding ARE shares at a price below $50 for patient investors reflects a cautious stance on the stock's short-term performance.
• Despite notable increases in stake by Oppenheimer Asset Management Inc., industry challenges and limited growth prospects in the coming years may have influenced the stock price negatively.
• Market response could be influenced by the broader sentiment towards the real estate sector, particularly with contrasting performances of companies like Ventas (VTR) observing significant revenue and net profit growth.

04.11.2025 - ARE Stock was down 7.1%

• ARE stock saw a substantial decrease of 10.05% in its value today.
• The decline in ARE's stock price is linked to alleged misleading statements concerning its Long Island City property, unsatisfactory Q3 financial results, failure to meet analyst projections, decreases in revenue, adjusted funds from operation, and occupancy rates.
• Legal actions initiated by Faruqi & Faruqi, LLP and Pomerantz LLP through a class action lawsuit heightened investor apprehensions and potentially added to the selling pressure on ARE shares.
• Despite a positive performance in the broader stock market on the same day, ARE lagged behind its competitors and major indices, suggesting internal company challenges that led to negative market sentiment.

04.11.2025 - ARE Stock was down 10.3%

• ARE stock underperformed, falling by 10.05%, hitting a 52-week low at $48.42, and trading 55.26% below its yearly high.
• The class action lawsuit against ARE for alleged securities fraud and below-expectation financial results in Q3 2025 likely contributed to the stock's decline.
• Weak guidance, dividend cuts, and declining bids for Warner Bros. Discovery among other factors led to the negative market sentiment towards ARE.
• Despite maintaining a strong dividend yield and analyst Outperform ratings, the company's recent financial performance and legal challenges have impacted investor confidence, resulting in the bearish movement.

06.00.2026 - ARE Stock was up 2.6%

• Today, ARE experienced a strong bullish movement in the market, despite facing legal challenges and allegations of securities fraud. The market movement can be attributed to several factors:
• The positive market sentiment towards real estate investment trusts (REITs) in the current economic landscape.
• Potential investor optimism regarding ARE's ability to navigate through the legal issues and maintain its position in the market.
• The company's strategic initiatives and strong fundamentals overshadowing the short-term legal uncertainties.
• The overall bullish trend in the real estate sector contributing to the positive movement in ARE's stock price.